Ostre białaczki szpikowe – leczenie postaci nawrotowych i opornych

Publication date: Available online 2 March 2015 Source:Acta Haematologica Polonica Author(s): Beata Piątkowska-Jakubas , Agnieszka Kunicka-Sporek Relapsed and refractory acute myeloid leukemia (AML) is defined by clinical and biologic features that predict their poor response to therapy. Despite even the most aggressive and well-developed strategies for treatment, most patients succumb to the disease. No currently available treatment has demonstrated consistent efficacy in terms of salvage therapy or long-term survival in this group of patients. This review will discuss some of the emerging strategies: targeted molecular therapies, novel cytotoxics, and immune-based therapies to treat relapsed and refractory AML patients.
Source: Acta Haematologica Polonica - Category: Hematology Source Type: research